Keeping an Eye on Tonix Pharmaceuticals Holding Corp (TNXP) After Insider Trading Activity

NUE

In a filing, Tonix Pharmaceuticals Holding Corp revealed its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug 21 ’25. In the deal valued at $36.03 per share,418 shares were bought. As a result of this transaction, Taylor Carolyn E. now holds 418 shares worth roughly $8857.42.

Then, Treco James bought 250 shares, generating $9,000 in total proceeds. Upon buying the shares at $36.00, the Director now owns 250 shares.

Before that, LEDERMAN SETH bought 4,000 shares. Tonix Pharmaceuticals Holding Corp shares valued at $86,200 were divested by the Chief Executive Officer at a price of $21.55 per share. As a result of the transaction, LEDERMAN SETH now holds 4,005 shares, worth roughly $84865.95000000001.

Noble Capital Markets initiated its Tonix Pharmaceuticals Holding Corp [TNXP] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including ROTH Capital’s analysts, who increased its forecast for the stock in mid April from “a Neutral” to “a Buy”. ROTH Capital also remained covering TNXP and has increased its forecast on August 18, 2017 with a “Buy” recommendation from previously “Neutral” rating. ROTH Capital revised its rating on September 07, 2016. It rated TNXP as “a Neutral” which previously was an “a Buy”.

Price Performance Review of TNXP

On Friday, Tonix Pharmaceuticals Holding Corp [NASDAQ:TNXP] saw its stock fall -5.99% to $21.19. Over the last five days, the stock has lost -11.71%. Tonix Pharmaceuticals Holding Corp shares have risen nearly 50.71% since the year began. Nevertheless, the stocks have fallen -35.75% over the past one year.

How much short interest is there in Tonix Pharmaceuticals Holding Corp?

A steep rise in short interest was recorded in Tonix Pharmaceuticals Holding Corp stocks on 2025-09-30, growing by 0.76 million shares to a total of 1.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 1.17 million shares. There was a rise of 39.2%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on February 17, 2016 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $10.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.